SIMPLEX TRADING, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is and the CUSIP is 74587V957. A total of 2 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$10
-81.8%
3,900
-75.0%
0.00%
Q2 2023$55
-31.2%
15,600
-40.2%
0.00%
Q1 2023$80
+86.0%
26,100
+155.9%
0.00%
Q4 2022$4310,200
+3300.0%
0.00%
Q3 2022$0
-100.0%
300
-25.0%
0.00%
Q2 2022$1,000
-93.8%
400
-93.2%
0.00%
Q1 2022$16,000
+14.3%
5,900
+25.5%
0.00%
Q4 2021$14,000
-81.8%
4,700
-43.4%
0.00%
Q3 2021$77,000
+1.3%
8,3000.0%0.00%
Q2 2021$76,0008,300
+23614.3%
0.00%
Q1 2021$0
-100.0%
35
-68.5%
0.00%
Q4 2020$113,000
-55.3%
111
-55.8%
0.00%
Q3 2020$253,000
-10.0%
251
-7.0%
0.00%
Q2 2020$281,000
+28.9%
270
+4.2%
0.00%
Q1 2020$218,000
-56.1%
259
-54.5%
0.00%
-100.0%
Q4 2019$497,000
-6.6%
569
+14.9%
0.00%
-50.0%
Q3 2019$532,000
+772.1%
495
+931.2%
0.00%
Q2 2019$61,000
-90.9%
48
-72.3%
0.00%
-100.0%
Q1 2019$671,000
-18.4%
173
-57.2%
0.00%0.0%
Q4 2018$822,000
+142.5%
404
+445.9%
0.00%
+100.0%
Q3 2018$339,000
-58.1%
74
-46.0%
0.00%
-66.7%
Q2 2018$810,000
+686.4%
137
+101.5%
0.00%
-40.0%
Q1 2018$103,000
+178.4%
68
-34.0%
0.01%
+150.0%
Q4 2017$37,000
+311.1%
103
+56.1%
0.00%
Q3 2017$9,000
-94.7%
66
-87.5%
0.00%
-100.0%
Q2 2017$171,000
+66.0%
529
+148.4%
0.01%
+75.0%
Q1 2017$103,000
-65.7%
213
-23.9%
0.00%
-77.8%
Q4 2016$300,000
+757.1%
280
-31.0%
0.02%
+800.0%
Q3 2016$35,000
-88.3%
406
+21.2%
0.00%
-90.0%
Q2 2016$299,000
-67.9%
335
+93.6%
0.02%
-73.0%
Q1 2016$931,000
+90.0%
173
+8.1%
0.07%
+94.7%
Q4 2015$490,000
+27.9%
160
-14.0%
0.04%
+35.7%
Q3 2015$383,000
+114.0%
186
+141.6%
0.03%
+86.7%
Q2 2015$179,000
+155.7%
77
+413.3%
0.02%
+87.5%
Q1 2015$70,000
-82.1%
15
-83.1%
0.01%
-83.0%
Q4 2014$392,000890.05%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 416$7,874,0000.25%
SIMPLEX TRADING, LLC 89$392,0000.05%
GROUP ONE TRADING, L.P. 900$170,0000.00%
Citadel Advisors 13,300$2,517,0000.00%
View complete list of PUMA BIOTECHNOLOGY INC shareholders